最新の財務諸表(Form-10K)によると、SS Innovations International Incの総資産は$31で、純損失は$-20です。
SSIIの主要な財務比率は何ですか?
SS Innovations International Incの流動比率は2.81、純利益率は-400、1株当たり売上高は$0.03です。
SS Innovations International Incの収益はセグメントまたは地域別にどのように分けられていますか?
SS Innovations International Inc の最大収益セグメントは System で、最新の利益発表における収益は 5,692,721 です。地域別に見ると、India が SS Innovations International Inc の主要市場であり、収益は 5,879,710 です。
SS Innovations International Incは収益を上げていますか?
いいえ、最新の財務諸表によると、SS Innovations International Incの純損失は$-20です。
SS Innovations International Incに負債はありますか?
はい、SS Innovations International Incの負債は11です。
SS Innovations International Incの発行済株式数は何株ですか?
SS Innovations International Incの総発行済株式数は170.72株です。
主要データ
前終値
$4.76
始値
$4.88
当日レンジ
$4.75 - $4.88
52週レンジ
$3.01 - $22.42
取引高
1.4K
平均取引高
98.8K
1株当たり利益(TTM)
-0.16
配当利回り
--
時価総額
$931.3M
SSIIとは何ですか?
SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. The company is headquartered in Fort Lauderdale, Florida and currently employs 378 full-time employees. The company went IPO on 2018-07-09. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset.